Advertisement

Topics

Scleroderma Research Foundation Company Profile

21:06 EDT 14th August 2018 | BioPortfolio


News Articles [725 Associated News Articles listed on BioPortfolio]

aTyr Pharma Presents Positive Lung and Skin Findings with ATYR1923 in a Translational Animal Model at the Scleroderma Foundation National Patient Education Conference

SAN DIEGO, July 26, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunologica...

A novel research partnership in AI to advance drug discovery, longevity and aging research

(Biogerontology Research Foundation) Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intelligence for drug discovery. The...

A novel research partnership in AI to advance drug discovery, longevity & aging research

(Biogerontology Research Foundation) Thursday, June 14, London, UK: Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intel...

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer

The close temporal association between onset of some connective tissue diseases and cancer suggests a paraneoplastic association. Adult patients with scleroderma with anti-RNA polymerase III autoantib...

Inspirational patient stories reveal the challenging realities of living with devastating rare disease

Boehringer Ingelheim unveils a new phase of "More Than Scleroderma: The Inside Story", and launches the new patient website www.morethanscleroderma.com. The global initiative highlights the importance...

Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals Presents Preclinical Data for its Lead Drug Candidate, EHP-101, in Both Multiple Sclerosis and Scleroderma

EHP-101 Demonstrates Potential for Remyelination and Disease Modification in Multiple Sclerosis Models; EHP-101 Prevents Skin and Lung Fibrosis in a Bleomycin Model of Scleroderma SAN DIEGO, CA / A...

Damon Runyon Cancer Research Foundation awards over $3.6 million to nine top clinical investigators

(Damon Runyon Cancer Research Foundation) The Damon Runyon Cancer Research Foundation named six new Damon Runyon Clinical Investigators at its spring 2018 committee review. The recipients of this pres...

Derfner Foundation funds novel research in regenerative medicine at Kessler Foundation

(Kessler Foundation) Kessler Foundation has received funding from the Derfner Foundation to support applying rehabilitation research to the area of regenerative medicine ('regenerative rehabilitation'...

PubMed Articles [1019 Associated PubMed Articles listed on BioPortfolio]

Improving life expectancy of patients with scleroderma. Results from the South Australian Scleroderma Register.

Scleroderma is a rare connective tissue disorder characterised by inflammation, vasculopathy and excessive fibrosis. Patients with scleroderma are known to have decreased life expectancy.

The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis.

The present review aims to summarize available knowledge on the role of the ubiquitin-proteasome system (UPS) in the pathogenesis of scleroderma and scleroderma-related disease mechanisms. This will p...

Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens.

In this study, we developed a series of synthetic oligonucleotides that allowed us to investigate the details on the antigen recognition by autoimmune antibodies in localized scleroderma subjects. Bes...

Challenges and strategies for coping with scleroderma: implications for a scleroderma-specific self-management program.

The purpose of this study was to explore challenges faced by patients with systemic sclerosis, also called scleroderma, in coping with their disease and the strategies they used to face those challeng...

Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?

The persistence of myofibroblasts is a key feature of fibrosis and in fibrotic diseases including scleroderma. This review evaluates the emerging concepts of the origins and cell populations that cont...

Clinical Trials [1408 Associated Clinical Trials listed on BioPortfolio]

The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)

The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certa...

Scleroderma Registry & Repository at the Hospital for Special Surgery

The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (H...

Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls

Scleroderma is an autoimmune disease of unknown origin. Recently, the role of environmental factors, and particularly toxic drug exposure, in the genesis of scleroderma has been suggested....

Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this tech...

Scleroderma Registry

Scleroderma is likely caused by a combination of factors, including an external trigger (infection or other exposure) and a genetic predisposition. The Scleroderma Registry will conduct ge...

Companies [2438 Associated Companies listed on BioPortfolio]

Scleroderma Foundation, Texas Bluebonnet Chapter

The Scleroderma Foundation is a 501(c)3 non-profit organization dedicated to serving the needs and interests of all those affected by scleroderma. Headquartered in Danvers, Mass., the Foundation's 22...

Scleroderma Research Foundation

The Scleroderma Foundation

Scleroderma Foundation, Southern California Chapter

Spendlove Research

The Spendlove Research Foundation was founded in 1989 and is funded through an endowment established by Dr. Rex S. and Reta Spendlove and family. Dr. Spendlove is the Founder of Hyclone Laboratories, ...

More Information about "Scleroderma Research Foundation" on BioPortfolio

We have published hundreds of Scleroderma Research Foundation news stories on BioPortfolio along with dozens of Scleroderma Research Foundation Clinical Trials and PubMed Articles about Scleroderma Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scleroderma Research Foundation Companies in our database. You can also find out about relevant Scleroderma Research Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record